AVENTIS PHARMA LIMITED t-a Sanofi: UK Public Sector Contracts Won & Awards
Large organisation·Reading·South East England·Main market: Pharmaceutical products
Official UK PPONPMBG-8218-QDPT
i
How many tenders this supplier has won.
Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.
i
How many different public bodies have awarded to this supplier.
Buyers named on its awards, with duplicate names merged.
i
Awards to this supplier in the last 12 months.
Award records dated in the last 12 months, against the two years before.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
i
Where this supplier has delivered.
Delivery regions published on its awarded tenders. A tender with several regions counts in each.
Where the work was, not where the company is based.
Where they wini
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
i
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
8 lot-level observations (8 awarded lots, 100%, plus 0 envelope awards without lot links; pending awards included) · top CPV classes
3360 Pharmaceutical products8 observations · 100% · lotsWhere they deliveri
Where this supplier has delivered.
Delivery regions published on its awarded tenders. A tender with several regions counts in each.
Where the work was, not where the company is based.
i
Where this supplier has delivered.
Delivery regions published on its awarded tenders. A tender with several regions counts in each.
Where the work was, not where the company is based.
ITL1 delivery regions on the notice · 5 of 5 awarded procedures publish one · a procedure with several regions counts in each
Bidding recordi
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
Procurement Act 2023 award notices name every bidder · 5 notices name this supplier since 18 Dec 2025 · observed bids, not an estimate
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Frameworks and DPS this supplier got onto.
Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.
i
How many public bodies this supplier has bid to.
Buyers on notices that name it as a bidder, win or lose.
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 | NHS England | appointed | 25 | 21 Jul 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | NHS England | appointed | 26 | 10 Jul 2026 |
| NHS National Branded Interim - 1 June 2026 | NHS England | appointed | 53 | 22 May 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | appointed | 118 | 26 Feb 2026 |
| NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products | NHS England | appointed | 11 | 18 Dec 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
Which buyers publish the most notices here.
Buyers ranked by the number of notices, duplicate names merged.
i
Which buyers publish the most notices here.
Buyers ranked by the number of notices, duplicate names merged.
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
i
What kinds of public bodies buy here.
Notices by the buyer’s type as published, otherwise by its name.
Central government100%(8 awards)
8 of 8 awards are Central government (100%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 5 | 100% | 8 | 21 Jul 2026 |
Share = of the 5 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
Published end dates only · 5 of 8 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| CM/PHR/25/5732 - Low Molecular Weight Heparins and Fondaparinux Products | 29 Feb 2028 | £321,349,256 |
Recent awards
Latest 8 of 8 award records naming this supplier
| Award / procedure | Authority | Awarded | Award value |
|---|---|---|---|
| Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & East | NHS England | 15 Jun 2026 | £665,389,588 |
| Lot 1 - CM/PHR/25/5731/01 – NHS Branded Medicines Tranche B for London & South of England. | NHS England | 1 Jun 2026 | £813,863,584 |
| NHS National Branded Interim - 1 June 2026 | NHS England | 10 Apr 2026 | £529,090,780 |
| Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products | NHS England | 13 Jan 2026 | £403,702,000 |
| NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins | NHS England | 28 Nov 2025 | £321,349,256 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 | NHS England | Not published | Not published |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | NHS England | Not published | Not published |
| NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products | NHS England | Not published | Not published |
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. Only awards made to this supplier alone count towards its value, excluding VAT and framework ceilings. It is not turnover.
- Regions on this page are where the work is delivered, not the supplier’s registered address.
- Contract end dates. Published on 5 of 8 awards; those feed “Contracts ending”.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.